Eman A Elghoroury1, Fatina I Fadel2, Manal F Elshamaa3, Dina Kandil1, Doaa M Salah2, Marwa M El-Sonbaty4,5, Hebatallah Farouk1, Mona Raafat1, Soha Nasr1. 1. Clinical & Chemical Pathology Department, National Research Centre, Cairo, Egypt. 2. Pediatric Department, Faculty of Medicine, Cairo University, Cairo, Egypt. 3. Pediatric Department, National Research Centre, Elbohous street, Cairo, Dokki, Postal code 12311, Egypt. manal_elshmaa@hotmail.com. 4. Taibah University, Al- Madinah Al- Munawwarah, Kingdom of Saudi Arabia. 5. Child Health Department, National Research Centre, Cairo, Egypt.
Abstract
BACKGROUND: Klotho G-395-A gene polymorphism may impact children with end-stage renal disease (ESRD). We investigated the relevance of Klotho G-395-A on ESRD development and progression, and its relationship with evolution of cardiovascular complications in pediatric dialysis patients. METHODS: Fifty-five children with chronic kidney disease (CKD) and seventy healthy children were genotyped for Klotho G-395A. RESULTS: Incidence of GA/AA genotypes and A allele were higher in ESRD patients compared with controls (54.5 vs. 7.1%, P < 0.001; 30.9 vs. 13.6%, P = 0.001, respectively). Also, children with GA/AA genotypes were 15.6 times more likely to develop ESRD than with GG genotype (95% CI 5.4-44.7, P < 0.001). A allele carriers have 2.8 times higher risk of developing ESRD than those with G allele (95% CI 1.5-5.35, P = 0.001). Also, the A allele could be considered a predictor of cardiovascular disease (CVD), as carriers have 161 times higher risk of cardiovascular complications than non-carriers (95% CI 21-1233, P < 0.001). All ESRD patients with CVD presented with left ventricular hypertrophy (LVH) and the frequency of A allele was significantly higher among ESRD children with LVH, whereas G allele frequency was significantly higher among ESRD children without LVH. CONCLUSIONS: The A allele of the G-395A Klotho gene polymorphism shows a significantly higher frequency among children with CKD and those with CVD and LVH. This mutant allele could be used as a risk marker for the development of ESRD as well as a predictor of CVD in these children.
BACKGROUND:Klotho G-395-A gene polymorphism may impact children with end-stage renal disease (ESRD). We investigated the relevance of Klotho G-395-A on ESRD development and progression, and its relationship with evolution of cardiovascular complications in pediatric dialysis patients. METHODS: Fifty-five children with chronic kidney disease (CKD) and seventy healthy children were genotyped for KlothoG-395A. RESULTS: Incidence of GA/AA genotypes and A allele were higher in ESRDpatients compared with controls (54.5 vs. 7.1%, P < 0.001; 30.9 vs. 13.6%, P = 0.001, respectively). Also, children with GA/AA genotypes were 15.6 times more likely to develop ESRD than with GG genotype (95% CI 5.4-44.7, P < 0.001). A allele carriers have 2.8 times higher risk of developing ESRD than those with G allele (95% CI 1.5-5.35, P = 0.001). Also, the A allele could be considered a predictor of cardiovascular disease (CVD), as carriers have 161 times higher risk of cardiovascular complications than non-carriers (95% CI 21-1233, P < 0.001). All ESRDpatients with CVD presented with left ventricular hypertrophy (LVH) and the frequency of A allele was significantly higher among ESRDchildren with LVH, whereas G allele frequency was significantly higher among ESRDchildren without LVH. CONCLUSIONS: The A allele of the G-395AKlotho gene polymorphism shows a significantly higher frequency among children with CKD and those with CVD and LVH. This mutant allele could be used as a risk marker for the development of ESRD as well as a predictor of CVD in these children.
Authors: Manal F Elshamaa; Samar Sabry; Ahmed Badr; Mostafa El-Ahmady; Eman A Elghoroury; Eman H Thabet; Dina Kandil; Solaf Kamel Journal: Blood Coagul Fibrinolysis Date: 2011-09 Impact factor: 1.276
Authors: Koichiro Kuwahara; Yanggan Wang; John McAnally; James A Richardson; Rhonda Bassel-Duby; Joseph A Hill; Eric N Olson Journal: J Clin Invest Date: 2006-11-09 Impact factor: 14.808
Authors: G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman Journal: J Am Coll Cardiol Date: 1992-11-01 Impact factor: 24.094
Authors: Hongjun Liu; Maria M Fergusson; Rogerio M Castilho; Jie Liu; Liu Cao; Jichun Chen; Daniela Malide; Ilsa I Rovira; Daniel Schimel; Calvin J Kuo; J Silvio Gutkind; Paul M Hwang; Toren Finkel Journal: Science Date: 2007-08-10 Impact factor: 47.728